X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/botanical-be-issues-voluntary-nationwide-recall-kuka-flex-forte-artri-king-and-reumo-flex-capsules
https://endpts.com/fda-warns-amazon-again-for-selling-unapproved-drugs-online/
https://www.globenewswire.com/news-release/2022/10/25/2540808/0/en/NEXGEL-Reports-Positive-Results-from-Proof-of-Concept-Study-for-its-Diclofenac-Hydrogel-Pain-Treatment.html
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/latin-foods-market-issues-voluntary-nationwide-recall-artri-king-reforzado-con-ortiga-y-omega-3-due
https://www.newswire.ca/news-releases/labelling-update-regarding-the-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-beyond-20-weeks-of-pregnancy-and-risk-of-kidney-damage-to-unborn-babies-866562162.html
https://www.perrigo.com/press-release/perrigo-announces-store-brand-equivalent-voltarenr-arthritis-pain-available-us-major
http://www.adnews.com.au/news/gsk-and-novartis-fined-4-5-million-for-misleading-marketing-of-voltaren/type/yafNews
https://www.contractpharma.com/contents/view_breaking-news/2020-05-22/virpax-completes-pre-ind-meeting-with-fda/
https://www.fiercepharma.com/pharma/gsk-alcon-switch-3-meds-from-prescription-only-to-otc-volume-play
https://www.fiercepharma.com/manufacturing/novartis-manufacturing-agreement-cited-syria-controversy
https://www.prnewswire.com/news-releases/perrigo-launches-its-ab-rated-generic-version-of-solaraze-gel-3-300755902.html
https://www.ema.europa.eu/documents/chmp-annex/start-community-reviews-chmp-meeting-15-18-october-2018_en.pdf
https://www.reuters.com/article/us-health-heart-diclofenac/common-painkiller-tied-to-increased-risk-of-heart-problems-idUSKCN1M12CD?feedType=RSS&feedName=healthNews
http://www.pharmabiz.com/NewsDetails.aspx?aid=111306&sid=1
https://www.biospectrumasia.com/news/25/11671/mundipharma-novartis-to-distribute-pain-medicine-in-se-asia.html
https://www.europeanpharmaceuticalreview.com/news/78774/common-painkiller-linked-to-an-increased-risk-of-heart-problems/
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-completes-acquisition-of-generic-products-and-assets-from-amnealimpax-300642867.html
https://www.reuters.com/article/us-health-nsaids-overdosing/many-people-take-dangerously-high-amounts-of-ibuprofen-idUSKBN1FS336
https://www.in-pharmatechnologist.com/Article/2017/12/06/GSK-and-Novartis-sued-following-claims-Voltaren-packaging-misleads-consumers
http://www.scoop.co.nz/stories/BU1708/S00533/commission-issues-warnings-to-gsk-and-aft.htm
http://www.biospace.com/News/philadelphia-drugmaker-iroko-pharma-pink-slips/458539/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.pharmatimes.com/news/study_links_nsaids_with_higher_risk_of_cardiac_arrest_1189035
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208098
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-diclofenac-capsules-generic-version/articleshow/55831926.cms
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207393
http://www.news-medical.net/news/20161117/FDA-approval-of-controversial-drug-for-Duchenne-muscular-dystrophy-raises-concern-and-hope.aspx?
http://www.pharma-excipients.ch/2016/10/30/gellan-gum-fluid-gels-for-topical-administration-of-diclofenac/
http://www.reuters.com/article/us-health-nsaids-heart-failure-idUSKCN12K2J1
http://www.pharma-excipients.ch/2016/09/20/evaluation-of-taste-masking-effect-of-diclofenac-using-sweeteners-and-cyclodextrin-by-a-potentiometric-electronic-tongue/
https://www.pharmacompass.com/pdf/news/glenmark-pharms-generic-diclofenac-sodium-approved-in-us-1474108765.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/gsk-healthcare-shifts-focus-from-horlicks-banks-on-sensodyne-crocin-to-drive-growth-in-india/articleshow/51706616.cms
http://www.forbes.com/sites/ritarubin/2016/03/18/tylenol-not-effective-for-arthritis-pain-study-concludes-and-other-drugs-arent-exactly-winners/#469b8b4517c8
http://twofourinsight.com/analyzing-data-earliest-market-entry-subsequent-anda-filers/
http://www.outsourcing-pharma.com/Clinical-Development/Better-data-can-encourage-industry-to-trial-generics-for-new-indications
http://www.financialexpress.com/article/pharma/latest-updates/madras-hc-stays-prosecution-over-multidose-diclofenac/185224/
http://www.forbes.com/sites/johnlamattina/2015/09/02/uk-study-indicates-that-the-cardiovascular-risk-of-celebrex-no-different-from-other-pain-drugs/
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53055a-eng.php
http://www.fdanews.com/articles/170849-ema-wants-updated-advice-on-cv-risk-of-high-dose-ibuprofen
http://www.raps.org/Regulatory-Focus/News/2015/03/09/21677/FDA-Provides-Generic-Approval-Roadmap-for-38-Drugs-Including-Vertexs-Kaldeco/
http://www.forbes.com/sites/larryhusten/2015/02/24/common-pain-drugs-linked-to-more-problems-after-a-heart-attack/
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43557a-eng.php
Market Place
Share 
